Please login to the form below

Not currently logged in
Email:
Password:

New Accounts, April, 2008 - PR & Med Ed

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period January to March 2008 inclusive

Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may not be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, email new_accounts@pmlive.com

CLIENT PRODUCT THERAPEUTIC WINNING AGENCY
Bayer Schering Pharma Rivaroxaban VTE Athena Medical PR
Biomarin Naglazyme Lysosomal Iceberg Medical
Goldshield Macrobid Anti-infective MSA Market Media
GSK Cervarix Vaccine Clew Communications
GSK and Roche Bonviva Osteoporosis Just:: Health PR
Hospira Nipent Oncology Ashley Communications
Johnson and Johnson Nicorette Smoking cessation Virgo Health PR
Leo Pharma Innohep DVT MSA Market Media
Norgine Global New Product n/a Euro RSCG Life UK
OnMedica n/a n/a Life Healthcare Communications
Organon Cezarette, Implanon and Nuvaring Contraception Virgo Health PR
Organon Sugammadex Anaesthesiology Aurora
Pharmion Refludan Haematology Life Leathcare Communications
Takeda Europe New Product n/a Euro RSCG Life UK
UCB (global) Cimzia Gastrointestinal MSA Market Media
UCB (global) Keppra Anti-epileptic MSA Market Media
UCB (Europe) Neupro Parkinson's diesease MSA Market Media

 

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics